Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster ...

It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline ...

Eli Lilly and Novo Nordisk dominate the market for weight loss drugs, and demand for their products has surpassed supply in recent times. Lilly’s weight loss portfolio has already delivered ...

Eli Lilly (NYSE: LLY) has produced a wide variety of treatments for various illnesses throughout its 145-year history. But this big pharma company truly took center stage over the past year or so ...

Eli Lilly announces a $3 billion expansion at its Pleasant Prairie facility, creating 750 jobs. Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other dividend stocks that beat the market in the last 3 years. The broader market has ...

Eli Lilly and Co. said Thursday that it has slated more than $23 billion to construct, expand or acquire manufacturing sites worldwide since 2020. Show comments Advertisement ...

Eli Lilly Invests $3B to Expand Wisconsin Factory to Help Meet Demand for Mounjaro, Zepbound Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke ...

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products. Lilly said Thursday it will expand a ...